News View all news
AAP updates ADHD treatment guidelines
For the first time since 2011, the American Academy of Pediatrics (AAP) has updated its guidelines on treating children and teens with ADHD—changing some criteria for diagnosis, adding current medications, and emphasizing the need to rule out other causes of symptoms. The Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents, published in the October 2019 issue of Pediatrics, emphasizes team-based care and better communication among health professionals, parents, and school staff.
200,000 uninsured Americans to get free HIV prevention drugs
HHS launched on Tuesday a program that will provide HIV prevention medications free of charge to 200,000 people without insurance. In an announcement, HHS Secretary Alex M. Azar described how the government plans to distribute the pre-exposure prophylaxis (PrEP) drugs for the Ready, Set, PrEP program.
Pharmacogenomic testing could benefit children who need PPIs
A new study from researchers at Vanderbilt University Medical Center is adding to the growing evidence that genetic variants of the CYP2C19 enzyme can affect how PPIs are metabolized. The variations may increase the level of medication in the body and lead to more adverse reactions, specifically infections.
Asthma management just got a little more precise and personalized
Clinicians are now learning that asthma, once considered a single disease entity, is a complex inflammatory disease with multiple pathways that affect the cause and severity of the disease, according to Amber Lanae Martirosov, PharmD, BCACP, BCPS, assistant clinical professor at Wayne State University and clinical pharmacy specialist at Henry Ford Health System in Detroit.
November 26, 2019
Thank you for all you do
Every day, you model the reasons that pharmacists must be increasingly incorporated into growing patient care roles across the health care spectrum. Yet, it’s little comfort to many of our own who…0 comments
November 5, 2019
APhA supports innovative legislation to reduce drug shortages
The American Pharmacists Association (APhA) today expressed its support for a bill that will provide new opportunities to address drug shortages and improve care. The Mitigating Emergency Drug Shortages (MEDS) Act, introduced by Sens. Susan Collins (R-ME) and Tina Smith (D-MN), aims to improve communications to pharmacists about drug shortages and mitigate the risks drug shortages pose to patient safety, among other benefits.
November 1, 2019
APhA Chief Operating Officer Elizabeth Keyes receives JFPS honor
American Pharmacists Association (APhA) Chief Operating Officer Elizabeth Keyes was recognized by the Joint Federal Pharmacy Seminar (JFPS) leadership during its recent annual meeting in Dallas, for her support of federal pharmacy programs, including JFPS.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.